Saibriga (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: Saibriga (Laos)

Saibriga is a Lao-manufactured generic of brigatinib, produced by BioSpring.LTD. It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard 90 mg maintenance dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, Saibriga delivers the same active ingredient as the originator at a lower, out-of-pocket-friendly price.

What Is Saibriga Used For?

Saibriga is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients whose disease has progressed on or who cannot tolerate crizotinib. It is an oral, once-daily monotherapy that is easy to take at home, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does Saibriga (Brigatinib) Work?

The brigatinib in Saibriga is a next-generation ALK tyrosine kinase inhibitor that also inhibits ROS1, IGF-1R, and FLT-3. It blocks the growth signals that drive ALK-positive cancer cells and crosses the blood-brain barrier, making it effective against brain metastases. The generic Saibriga carries the same active ingredient and mechanism as the originator at a lower cost.

Indications

Saibriga is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. It is not appropriate for ALK-negative disease and is not indicated for small-cell lung cancer.

Dosage

The recommended regimen is 90 mg once daily for 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food and swallow it whole. If a dose is missed or vomited, do not take an extra tablet — continue with the next scheduled dose.

Side Effects

Common adverse reactions include diarrhea, rash, cough, hypertension, fatigue, nausea, muscle pain, and headache. Blood pressure should be monitored during treatment, and diarrhea is generally manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store Saibriga below 30°C in a dry place, in its original container, and out of the reach of children. No refrigeration is required.

Why Choose the GLT?

For uninsured or under-insured patients, a Lao generic such as Saibriga offers a substantial saving over the originator brand, whose Western list price is very high. GLT sources from established manufacturers and provides the documentation required for safe international shipping, helping patients maintain affordable and continuous therapy.

How to Order

To order Saibriga through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Provide the strength, quantity, and destination country, and we will confirm availability, sourcing origin, and delivery terms. We support both institutional purchasers and individual patients.

FAQ

Is Saibriga a generic of Alunbrig? Yes. Saibriga is a Lao-manufactured generic of brigatinib, the active ingredient in Alunbrig, produced by BioSpring.LTD.

What strength does Saibriga come in? This listing is the 90 mg strength in a 30-tablet box, matching the lead-in and standard 90 mg maintenance dose.

Can I buy generic brigatinib online? Generic brigatinib can be purchased through international suppliers such as GLT. Always confirm the supplier's legitimacy and request proper documentation before ordering.

Related Oncology Products

Tixepa (Тирзепатид) 20мг/2мл и 30мг/2мл многодозовая ручка | Drug International | GLT

Tixepa — многодозовая ручка тирзепатида Drug International Limited (DIL), две официальные дозировки (Tixepa-5 = 20мг/2мл,...

Avabopa (Аватромбопаг) 20 мг × 30 таблеток | Tongmeng TLPH Лаос | GLT

Avabopa — аватромбопаг 20 мг от Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), регистрация...

KeZeRui 科瑞泽 (Аватромбопаг) 20мг*10 таб. | Sichuan Kelun (Китай) | GLT

KeZeRui — аватромбопаг национальной закупки от Sichuan Kelun Pharmaceutical, интегрированного китайского производителя АФС и таблеток.

Rizonib (Кризотиниб) 250 мг капсулы | Дженерик Xalkori из Бангладеш (DIL) для ALK+ НМРЛ | GLT

Rizonib 250 от Drug International Ltd (DIL), Тонги Газипур — доступный дженерик кризотиниба из Бангладеш

XinKePing 欣可平 (Аватромбопаг) 20 мг × 10 таблеток | Nanjing Hencer, Китай | GLT

XinKePing — аватромбопаг Nanjing Hencer Pharmaceutical (группа Jemcare), полная вертикальная интеграция АФС и таблеток, материковый...

AVATODX (Аватромбопаг) 20мг*30 таб. | Bigbear Pharmaceutical (Лаос) | GLT

AVATODX — аватромбопаг 20 мг от Bigbear Pharmaceutical (Lao) Co., Ltd., лаосский рег. № 06L0985/23,...

Barinat (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Natco Pharma Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Natco Pharma Limited (Индия) — доступная альтернатива Olumiant при ревматоидном...

Zepbound (Тирзепатид) 2,5–15мг/0,5мл одноразовая шприц-ручка | Eli Lilly (США) | GLT

Zepbound — одноразовая шприц-ручка тирзепатида Eli Lilly, шесть дозировок для США (2,5–15мг/0,5мл) для хронического контроля...